These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2472808)

  • 1. Conformationally dependent epitopes of bluetongue virus neutralizing antigen.
    Grieder FB; Schultz KT
    Viral Immunol; 1989; 2(1):17-24. PubMed ID: 2472808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformation of the VP2 protein of bluetongue virus (BTV) determines the involvement in virus neutralization of highly conserved epitopes within the BTV serogroup.
    White JR; Eaton BT
    J Gen Virol; 1990 Jun; 71 ( Pt 6)():1325-32. PubMed ID: 1693664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing epitopes of the serotypes of bluetongue virus present in the United States.
    Rossitto PV; MacLachlan NJ
    J Gen Virol; 1992 Aug; 73 ( Pt 8)():1947-52. PubMed ID: 1379625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of four distinct neutralizing epitopes on bluetongue virus serotype 10 using neutralizing monoclonal antibodies and neutralization-escape variants.
    Heidner HW; Rossitto PV; MacLachlan NJ
    Virology; 1990 Jun; 176(2):658-61. PubMed ID: 1693250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies to bluetongue virus define two neutralizing epitopes and a hemagglutinating epitope.
    Mecham JO; Jochim MM
    Viral Immunol; 1990; 3(2):161-70. PubMed ID: 1694430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiidiotypic antibody mimicry of a bluetongue virus neutralizing antigen.
    Grieder FB; Schultz KT
    J Immunol; 1990 Apr; 144(7):2627-31. PubMed ID: 1690772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation amongst the neutralizing epitopes of bluetongue viruses isolated in the United States in 1979-1981.
    MacLachlan NJ; Rossitto PV; Heidner HW; Iezzi LG; Yilma TD; DeMaula CD; Osburn BI
    Vet Microbiol; 1992 Jun; 31(4):303-16. PubMed ID: 1379766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homotypic and heterotypic neutralization determinants of bluetongue virus serotype 17.
    Pierce CM; Rossitto PV; MacLachlan NJ
    Virology; 1995 May; 209(1):263-7. PubMed ID: 7538255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic topography of bluetongue virus 17.
    Grieder FB; Schultz KT
    Microb Pathog; 1990 Apr; 8(4):299-303. PubMed ID: 1696679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralization determinants of United States bluetongue virus serotype ten.
    DeMaula CD; Heidner HW; Rossitto PV; Pierce CM; MacLachlan NJ
    Virology; 1993 Jul; 195(1):292-6. PubMed ID: 7686312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a neutralizing epitope shared by bluetongue virus serotypes 2 and 13.
    Ristow S; Leendersten L; Gorham J; Yilma T
    J Virol; 1988 Jul; 62(7):2502-4. PubMed ID: 2453681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and localization of a serotypic neutralization determinant on the VP2 protein of bluetongue virus 13.
    Hwang GY; Li JK
    Virology; 1993 Aug; 195(2):859-62. PubMed ID: 7687805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro neutralization of antigenic variants of bluetongue virus is related to in vivo protection.
    Sundin DR; Dean VC; DuBard KM; Mecham JO
    Viral Immunol; 1989; 2(3):195-203. PubMed ID: 2560915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody analysis of serotype-restricted and unrestricted bluetongue viral antigenic determinants.
    Appleton JA; Letchworth GJ
    Virology; 1983 Jan; 124(2):286-99. PubMed ID: 6186076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic profile of African horse sickness virus serotype 4 VP5 and identification of a neutralizing epitope shared with bluetongue virus and epizootic hemorrhagic disease virus.
    Martínez-Torrecuadrada JL; Langeveld JP; Venteo A; Sanz A; Dalsgaard K; Hamilton WD; Meloen RH; Casal JI
    Virology; 1999 May; 257(2):449-59. PubMed ID: 10329555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host-dependent variation of bluetongue virus neutralization.
    Grieder FB; Schultz KT
    J Invertebr Pathol; 1991 Jan; 57(1):37-42. PubMed ID: 1705948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralization epitopes on poliovirus type 3 particles: an analysis using monoclonal antibodies.
    Ferguson M; Minor PD; Magrath DI; Qui YH; Spitz M; Schild GC
    J Gen Virol; 1984 Jan; 65 ( Pt 1)():197-201. PubMed ID: 6198447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A complex neutralization domain of bluetongue virus serotype 17 defines a virulence-associated marker.
    Bernard KA; Israel BA; Schultz KT
    Viral Immunol; 1996; 9(2):97-106. PubMed ID: 8822626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-neutralization of genetic reassortants of bluetongue virus serotypes 20 and 21.
    Cowley JA; Gorman BM
    Vet Microbiol; 1989 Jan; 19(1):37-51. PubMed ID: 2466366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of neutralization-related epitopes within a bluetongue virus serotype.
    Letchworth GJ; Appleton JA
    Virology; 1983 Jan; 124(2):300-7. PubMed ID: 6186077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.